4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002405
Chief Executive Officer bought 15,000 shares at $0.69 ($10,409)
From the SEC's structured data for this filing
Trades in this filing
Climaco John M · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-12 | Purchase : show line 1 in the form | +15,000 | $0.69 | $10,409 | 45,010 | D |
| Open-market purchases · 15,000 sh · avg $0.69 · $10,409 | ||||||
Loading xslF345X04/ownership.xml…